HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,040
-530 (-3.91%)
Oct 10, 2025, 3:30 PM KST

HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 183.11 billion as of October 10, 2025. Its market cap has decreased by -51.43% in one year.

Market Cap
183.11B
Enterprise Value
170.76B
Revenue
36.10B
Ranking
n/a
PE Ratio
387.41
Stock Price
13,040.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 183.11B, an increase of 117.27%. That is a compound annual growth rate of 8.23%.

History

DateMarket Cap% Change
Oct 10, 2025183.11B-45.89%
Dec 30, 2024338.42B58.45%
Dec 28, 2023213.58B43.49%
Dec 29, 2022148.85B-21.48%
Dec 30, 2021189.57B-21.05%
Dec 30, 2020240.12B219.34%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro
Dec 21, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Samsung Biologics72.17T
Celltrion38.24T
ALTEOGEN24.66T
Yuhan9,028.52B
SK Biopharmaceuticals8,136.75B
Peptron6,866.96B
PharmaResearch5,631.19B
LigaChem Biosciences5,483.63B
Market Cap Rankings